Q0519 Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription injectable drug, per 30-days

Short descriptor: Supply fee hiv prep inj 30

⚠ Terminated HCPCS Level II 2026
Terminated Code
Q0519 was terminated as of 2024-12-31 and should not be reported for dates of service after that date. This page is retained for historical reference.
Open Q0519 in the app →

Look up Q0519 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

Q0519 is the HCPCS Level II code for Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription injectable drug, per 30-days (2026). It belongs to Section Q — Temporary Codes. Under Medicare, its coverage status is: Special coverage instructions apply. Part B pricing methodology: Carrier priced.

Classification & CMS Attributes

Medicare Coverage
Special coverage instructions apply (code D)
Part B Pricing
Carrier priced (indicator 46)
Type of Service
Other medical items or services
Effective Date
2025-01-01
Termination Date
2024-12-31
2026 Maintenance
No change this year

References

Cite This Page

Reference Q0519 with the canonical source and edition:

Q0519 — Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription injectable drug, per 30-days. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/Q0519

Canonical URL: https://icd10codingpro.com/hcpcs-codes/Q0519

Related Codes in Section Q

← Q0518 Supply fee hiv prep oral 90 Q0520 → Supply fee hiv prep inj 60
Q0515 Sermorelin acetate injection Q0516 Supply fee hiv prep oral 30 Q0517 Supply fee hiv prep oral 60 Q0518 Supply fee hiv prep oral 90 Q0520 Supply fee hiv prep inj 60 Q0521 Supply fee hiv prep fda appr Q1004 Ntiol category 4 Q1005 Ntiol category 5 Q2004 Bladder calculi irrig sol Q2009 Fosphenytoin inj pe
Browse all HCPCS Level II sections →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2026-01-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial